Evidence map›Paper›PMID 30367868›Full record

ArticleInternational journal for parasitology2019

A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology.

Catherine M Elton, Marilis Rodriguez, Choukri Ben Mamoun, Cheryl A Lobo, Gavin J Wright

Open access · hybridAbstract read
In one paragraph

Article in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Identification ofInfection and immunity · 2024
    Article
  6. Article
  7. Advances inPathogens (Basel, Switzerland) · 2023
    Review
  8. Frontiers in cellular and infection microbiology · 2023
    Article
  9. Article
  10. Article
  11. Major Surface Antigens in ZoonoticPathogens (Basel, Switzerland) · 2022
    Review
  12. HarnessingVaccines · 2022
    Review
  13. Frontiers in microbiology · 2022
    Article
  14. Article
  15. Probing theBiomedicines · 2021
    Article
  16. Frontiers in microbiology · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Catherine M EltonCell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom.
Marilis RodriguezNew York Blood Center, Blood Borne Parasites, 310 E. 67th Street, New York, NY 10065, USA.
Choukri Ben MamounInfectious Diseases, PO Box 208056, 333 Cedar Street, New Haven, CT 06520-8056, USA.
Cheryl A LoboNew York Blood Center, Blood Borne Parasites, 310 E. 67th Street, New York, NY 10065, USA.
Gavin J WrightCell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom. Electronic address: gw2@sanger.ac.uk.
New York Blood Center · USWellcome Sanger Institute · GB

Funding

Wellcome Trust 206194
6 · The paper itself

Abstract

Human babesiosis is an emerging tick-borne parasitic disease and blood transfusion-transmitted infection primarily caused by the apicomplexan parasite, Babesia microti. There is no licensed vaccine for B. microti and the development of a reliable serological screening test would contribute to ensuring the safety of the donated blood supply. The recent sequencing of the B. microti genome has revealed many novel genes encoding proteins that can now be tested for their suitability as subunit vaccine candidates and diagnostic serological markers. Extracellular proteins are considered excellent vaccine candidates and serological markers because they are directly exposed to the host humoral immune system, but can be challenging to express as soluble recombinant proteins. We have recently developed an approach based on a mammalian expression system that can produce large panels of functional recombinant cell surface and secreted parasite proteins. Here, we use the B. microti genome sequence to identify 54 genes that are predicted to encode surface-displayed and secreted proteins expressed during the blood stages, and show that 41 (76%) are expressed using our method at detectable levels. We demonstrate that the proteins contain conformational, heat-labile, epitopes and use them to serologically profile the kinetics of the humoral immune responses to two strains of B. microti in a murine infection model. Using sera from validated human infections, we show a concordance in the host antibody responses to B. microti infections in mouse and human hosts. Finally, we show that BmSA1 expressed in mammalian cells can elicit high antibody titres in vaccinated mice using a human-compatible adjuvant but these antibodies did not affect the pathology of infection in vivo. Our library of recombinant B. microti cell surface and secreted antigens constitutes a valuable resource that could contribute to the development of a serological diagnostic test, vaccines, and elucidate the molecular basis of host-parasite interactions.

Indexed as

AnimalsAntigens, ProtozoanAntigens, SurfaceBabesia microtiBabesiosisGene LibraryGenetics, MicrobialHumansMiceMolecular BiologySerologic TestsVaccinologyAntigens, ProtozoanAntigens, SurfaceApicomplexaBabesiaDiagnosticsSerologyVaccine

Identifiers

PMID30367868
PMCPMC6406021
OpenAlexW2898451834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.